Advances in the field of genomics have enabled computational analysis of metabolic pathways at the genome scale. Singular attention has been devoted in the literature to stoichiometric approaches, and path-finding approaches, to metabolic pathways. Stoichiometric approaches make use of reaction stoichiometry when trying to determine metabolic pathways. Stoichiometric approaches involve elementary flux modes and extreme pathways. In contrast, path-finding approaches propose an alternative view based on graph theory in which reaction stoichiometry is not considered. Path-finding approaches use shortest path and k-shortest path concepts. In this article we give a critical overview of the theory, applications and key research challenges of stoichiometric and path-finding approaches to metabolic pathways.
INTRODUCTION
Cellular metabolism is a highly complex biological process by which the cell produces the energy and material necessary for the maintenance of life. In order to better comprehend the intricate functioning of this process, cellular metabolism has been commonly organized into metabolic pathways. Traditionally, biochemistry has defined a metabolic pathway as a sequence of enzyme-catalysed reactions by which a living organism transforms an initial source compound into a final target compound [1] . Experimental findings on different organisms indicate that (despite the presence of many possible biochemically feasible pathways) organisms often have a single 'preferred' pathway in order to convert a source compound into a target compound. Such findings are reflected in, for example, standard textbooks such as [1] ; or online resources such as BioCyc (http://biocyc.org/). Here the terminology is not unique and different authors describe these pathways using different terms, e.g. annotated pathway [2, 3] ; consensus pathway [4] ; experimentally determined pathway [5, 6] ; experimentally elucidated pathway [7] ; reference pathway, KEGG Pathway Database, http://www.genome.ad.jp/ kegg/pathway.html. Of course it is important to note that from the physiological viewpoint metabolic pathways do not operate in isolation and within an organism many different pathways work together to produce an overall global flux (reaction/compound) distribution.
For those organisms in which experimentally determined metabolic pathway knowledge is sparse, availability of genome sequence data has enabled metabolic pathways to be inferred computationally. A number of qualitative tools have been developed to achieve this by assigning identified enzymes to experimentally determined (reference) pathways [8] [9] [10] . However, the scope of these tools is restricted by prior knowledge of experimentally determined metabolic pathways and they find difficulties, for example, in the discovery of novel alternative metabolic pathways which may be of interest for biotechnological or biomedical reasons.
Advances in genomics have produced knowledge of many of the biochemical reactions involved in a particular organism or cell, along with their underlying data: compounds, stoichiometry, reversibility, enzymes and genes [11, 12] . The interaction of the entire set of biochemical reactions and compounds is usually characterized as a directed graph and referred to as a genome-scale metabolic network. Figure 1 shows an example network comprising eight reactions (labelled R1-R8, respectively) and eight compounds (labelled C1-C8, respectively). Reaction R3, for example, converts one molecule of C5 into two molecules of C4, one molecule of C6 and one molecule of C7. Each reaction has a specified direction so a reversible reaction contributes two different reactions. For example, R6 and R7 are the reverse of each other. Such graphtheoretic representations provide a framework for a complete computational search for functional metabolic pathways within the genome-scale metabolic network.
Although not explicitly shown as such Figure 1 is a bipartite graph, since there are no reaction to reaction arcs, nor any compound to compound arcs. Other graphical representations are possible [13] , but we have found the representation shown to be the most useful.
To illustrate approaches to the computational analysis of metabolic pathways suppose that we are concerned with finding pathways which convert C1 into C7 in the network shown in Figure 1 . A pathway, as illustrated in Figure 2A , will be a subgraph of this entire network satisfying the condition that for each reaction node included in the subgraph all compound nodes associated with that reaction node (either as an input compound or as an output compound) also appear in the subgraph. In Figure 2A the subgraph comprises reactions nodes R1, R2 and R3, plus all of their associated compound nodes. As one might expect, within the metabolic network there may be more than one pathway, and Figure 2B shows another possible pathway that converts C1 into C7.
However, not each possible pathway will be biologically meaningful, i.e. will have a valid biochemical/physiological interpretation in the cell/organism. Thus, approaches to metabolic pathways aim to find biologically meaningful metabolic pathways within the metabolic network. The ability of an approach to find (known) experimentally determined pathways will provide insight into how well an approach might detect (novel, unknown) metabolic pathways useful for biotechnological or biomedical purposes.
Computational/mathematical approaches to metabolic pathways can be conveniently divided into two types: stoichiometric approaches and path-finding approaches. Under different mathematical perspectives there are two key distinctions between these approaches:
Stoichiometric approaches make direct use of reaction stoichiometry, path-finding approaches do not. Stoichiometric approaches seek the complete pathway, path-finding approaches focus on finding a directed path within the pathway.
As stoichiometric approaches appeared earlier in the literature, we begin by describing these approaches.
STOICHIOMETRIC APPROACHES
Stoichiometric approaches aim to find pathways in which the compound nodes satisfy a variety of different, but biochemically meaningful, stoichiometric constraints. Following the example described above, suppose now we are concerned with the problem of finding pathways converting a source compound, C1, into a target compound, C7, such that a subset of compounds, for example {C2, C5, C8}, are balanced. Here by balanced we are referring to a stoichiometric related balance, namely a compound is balanced if the total number of molecules consumed by the reactions involved in the pathway is equal to the total number of molecules produced by the reactions involved in the pathway.
Unbalanced compounds are either, in aggregate (net) terms, produced or consumed. Clearly the source compound, C1, must be, in aggregate, consumed (total number of molecules of C1 produced by the reactions involved in the pathway is less than the total number of molecules of C1 consumed by the reactions involved in the pathway). Similarly the target compound, C7, must be, in aggregate, produced (total number of molecules of C7 produced by the reactions involved in the pathway is greater than the total number of molecules of C7 consumed by the reactions involved in the pathway). Note here that, for the purposes of illustration, we assume that the source and target compound are different.
The reason to balance a subset of compounds, such as {C2, C5, C8}, is that some compounds can be regarded as present in the organism (e.g. cell) as represented by the metabolic network (such as in Figure 1 ) purely as intermediate compounds necessary for producing other, more crucial, compounds. The remaining compounds, {C3, C4, C6} for this eight compound example, are stoichiometrically unconstrained, i.e. they could be produced, balanced or consumed. They represent cofactors as well as other compounds such as water or hydrogen (ions). A cofactor is generally defined as a biochemical compound that fulfils the same specific and secondary function in a considerable number of reactions. One point to note is that the list of cofactors for a given metabolic network has not been defined unambiguously.
Other approaches [14, 15] include exchange reactions in the metabolic network so as to balance (if necessary) compounds. An exchange (transfer) reaction usually involves a physical transportation from the internal organism to the external environment. For instance in Figure 1 both C4 and C7 have no reactions to which they provide input, and hence must both have exchange reactions, namely C4!C4(external) and C7!C7(external), otherwise they would build up as the organism operates. However, the criteria as to how the exchange reactions are included has not been unambiguously defined [16] . Moreover explicitly adding to Figure 1 compounds such as C4(external) and C7(external) merely (in graph-theoretic terms) transfers the problem of unbalanced compounds from the internal compounds {C4, C7} to the external compounds {C4(external), C7(external)}, since these compounds can only themselves be balanced by further consideration of the external environment. For the sake of simplicity, therefore, we will neglect exchange reactions here, assuming that unbalanced compounds may be balanced (if necessary) by such reactions.
In order to consider stoichiometric approaches mathematically let R be the total number of reactions in the metabolic network and let t r be the number of ticks of reaction r in the pathway under consideration. This variable must take integer values, having the value zero if the reaction is not used. The tick variable for a reaction relates to its associated stoichiometry. In Figure 1 , for example, one tick of reaction R3 converts one molecule of C5 into two molecules of C4, one molecule of C6 and one molecule of C7. Two ticks of reaction R3 converts two molecules of C5 into four molecules of C4, two molecules of C6 and two molecules of C7; etc.
A particular pathway can be fully represented by its associated tick vector, [t 1 , t 2 , . . ., t R ]. In other work [14, 15] the ticks are usually referred to as reaction fluxes. In contrast, reaction fluxes are allowed to take continuous values (whereas ticks take integer values). It is important to note that both reaction fluxes and ticks are proportional to the absolute fluxes operating inside the organism. An absolute flux is a physiological variable that measures the rate at which the concentration of substrates are degraded (and products synthesized) per unit of time in a particular reaction. The absolute fluxes depend on many different factors (other pathways, environmental conditions, kinetics, etc). Because we are concerned with the structural non-dynamic problem of finding pathways, it is appropriate to define the tick vector as a discrete (integer-valued) vector.
Let S cr be the stoichiometric coefficient of compound c in reaction r (defined as, for one tick of reaction r, the number of molecules of compound c produced as output minus the number of molecules of compound c consumed as input). Then compound c constrained to being, in aggregate (net) terms, consumed implies that P R r¼1 S cr t r < 0 must be satisfied.
Here, as mentioned above, we are interested in pathways from C1 to C7. In order to ensure that the source compound C1 is consumed, pathways in the metabolic network shown in Figure 1 must satisfy:
A compound c constrained to being, in aggregate (net) terms, produced must satisfy P R r¼1 S cr t r > 0. Hence, in order to ensure that the target compound C7 is produced, pathways in the metabolic network shown in Figure 1 must satisfy:
Finally, a compound c constrained to being, in aggregate (net) terms, balanced must satisfy P R r¼1 S cr t r ¼ 0. Hence, in order to ensure that {C2, C5, C8} are balanced, pathways in the metabolic network shown in Figure 1 must satisfy: Figure 3A shows an example pathway that satisfies constraints (1)-(3). Here {C2, C5, C8} are balanced, two of these compounds {C2, C5} being involved in the pathway, the other {C8} not being involved. In Figure 3A The criteria by which the stoichiometric constraints are systematically imposed is clearly crucial, as the constraints define the set of possible pathways converting C1 into C7. Indeed, different stoichiometric constraints produce a different solution space. Figure 3B shows a pathway converting C1 into C7 that satisfies different stoichiometric constraints, {C3, C5, C8} balanced. In this case the pathway shown in Figure 3B would not satisfy the stoichiometric constraints defined in (1)- (3).
Stoichiometric approaches have focused on the identification of all the pathways that satisfy given stoichiometric constraints. The key assumption here is that experimentally determined pathways are expected to satisfy the stoichiometric constraints, thus the experimentally determined pathway should be found amongst the complete set of pathways satisfying the mathematical stoichiometric constraints.
However, typically the large number of pathways that satisfy the stoichiometric constraints means that complete enumeration of these pathways would be computationally impracticable. This issue is usually referred to as 'combinatorial explosion', and is mentioned further below. Subsequently, as described in the next section, stoichiometric approaches have developed to focus on finding a set of pathways capable of spanning the complete solution space of pathways defined by the stoichiometric constraints.
Development of stoichiometric approaches
The work of Seressiotis and Bailey [17, 18] constitutes the first stoichiometric approach for the computational analysis of metabolic pathways. They presented an algorithm to find a set of genetically independent pathways by the successive addition of reaction steps transforming a source compound into a target compound. For a pathway P to be genetically independent it means that there exists no other pathway (from source to target) utilizing just a subset of the enzymes used in P.
In their approach compounds involved in the pathway are constrained to be balanced, except for the source/target compounds and a cofactor set (although the constituents of this set are not clearly defined). They dealt with only a relatively small metabolic network (70 reactions, 100 compounds). However, the computational effort required of the algorithm prohibited its application to larger networks. Their work is of importance due to the fact that the concept of genetically independent pathways was established. In order to clarify this concept, consider three different pathways in the network shown in Figure 1 that convert C1 into C7 and satisfy the constraint that {C2, C5, C8} are balanced. In terms of their tick vector representation these are:
In the approach that Seressiotis and Bailey [17, 18] adopted it was wrongly assumed (albeit based on what was known at the time) that we have a one-to-one unique association between gene-enzyme and enzymereaction. In other words one gene is uniquely associated with one enzyme and that enzyme in turn is uniquely associated with one reaction. Under this assumption let the genes be g1, g2, . . ., g8 each (by implication) having a unique one-to-one association with R1, R2, . . ., R8, respectively. Thus each metabolic pathway, involving a number of reactions, can be assigned a specific set of genes, referred to as genotypes,
and G 3 ¼ {g1, g2, g3, g5, g8} to P 3 ¼ {R1, R2, R3, R5, R8}. Both G 1 (equivalently P 1 ) and G 2 (equivalently P 2 ) are genetically independent, since in each case no subset can generate a pathway from C1 into C7 that satisfies the stoichiometric constraints. However G 3 (equivalently P 3 ) is dependent as it contains a subset, namely G 1 (where
, that is a pathway from C1 to C7 satisfying the stoichiometric constraints. Hence, only P 1 and P 2 are genetically independent. Note here that the concept of genetic independence differs from the concept of linear independence. Here, P 1 , P 2 and P 3 are linearly independent, in particular there do not exist scalars 1 , 2 2 (À1, þ 1) such that
Genetic independence is defined above in relation to whether, or not, a single pathway contains a valid subset that is also a pathway. However, since our focus in this section is on sets of pathways, it is convenient to define genetic independence in a slightly different way. Let P Ã be the set of all pathways which satisfy the stoichiometric constraints, r be a particular pathway belonging to P Ã , and G r be the genotype associated with r. Then a pathway r is genetically independent if and only if there does not exist 2 P Ã such that G & G r This condition says that a pathway r is genetically independent if there is no other pathway for which the genotype G is a subset of G r .
In order to clarify the concept of genetically independent pathways, we have calculated manually (as we are not aware of suitable software for the purpose) the genetically independent metabolic pathways within the metabolic network shown in Figure 1 that convert C1 into C7, subject to {C2, C5, C8} being balanced. We obtained the three genetically independent pathways shown in Figure 4 .
Mavrovouniotis [19] [20] [21] presented an algorithm to generate genetically independent pathways satisfying a given set of stoichiometric constraints. In contrast to [17, 18] the algorithm deals with pathways which comprise multiple sources and targets, but it requires the specification of compound and reaction status (e.g. which compounds must be consumed in the pathway). The algorithm was applied to metabolic networks of moderate size (250 reactions, 400 compounds).
After these early approaches, much effort was expended to provide a more theoretical foundation to the study of metabolic pathways. Different works on inorganic reaction networks [22] [23] [24] [25] served as an inspiration for subsequent stoichiometric approaches. In these approaches the organism is (essentially) considered as an open system, consuming nutrients and producing biomass, in which enzymatic reactions interact to produce an overall global flux distribution. Let f r be the absolute flux of enzymatic reaction r, x c be the concentration of compound c and b c be the external flux for compound c, then applying the law of conservation of mass we have that dx c =dt ¼ b c þ P R r¼1 S cr f r 8c. The compound set is divided into two subsets: internal compounds, I-those compounds that cannot traverse the physical boundaries of the organism; and external compounds, E-those compounds that are able to traverse the physical boundaries of the organism. The external flux b c is equal to zero for internal compounds, whilst for external compounds it can be different from zero.
The main assumption here is that the concentration of internal compounds remains constant over time. This is usually referred to as the pseudo-steady state (henceforth PSS) condition. Thus, internal compounds satisfy dx c =dt ¼ b c þ P R r¼1 S cr f r ¼ 0 8c 2 I. As b c ¼ 0 8 c2I, this is P R r¼1 S cr f r ¼ 0 8c 2 I. We regard the system as being in a PSS condition since, when studying aspects of metabolism related to growth, the time constants associated with growth are much larger than those associated with individual reaction kinetics [14] .
In the context of PSS systems, metabolic pathways are regarded as structural elementary units in the organism that preserve the steady-state equilibrium for the whole organism. This view of metabolic pathways provides a link between the absolute flux and structural (ticks) view of metabolic pathways. Hence the concept of a metabolic pathway was redefined to be a set of enzyme catalysed biochemical reactions that satisfies two conditions: (i) the PSS condition and (ii) a simplicity condition.
A pathway at PSS satisfies the condition that the internal compounds appearing in the pathway are stoichiometrically balanced, i.e. P R r¼1 S cr t r ¼ 0 8c 2 I. Note here that external compounds (c 2 E) are stoichiometrically unconstrained, i.e. they could be produced, consumed or balanced. Indeed, they are not necessarily involved in the pathway. This is fundamentally different from previous approaches [17] [18] [19] [20] [21] in which pathways necessarily consumed a source compound(s) and produced a target compound(s).
In order to define the simplicity condition, the genetic independence condition of [17, 18] was reformulated to develop the non-decomposability condition. In the early work of [17, 18] it was wrongly assumed, as mentioned above, that there is a one-to-one unique association between geneenzyme and enzyme-reaction. In the post-genomic era, it is clear that a gene can express different enzymes and different enzymes can catalyse the same reaction. Let Q Ã be the set of all pathways which satisfy the PSS condition, r be a particular pathway belonging to Q Ã , and F r be the set of reactions involved in pathway r. Then, a pathway r is nondecomposable if and only if there does not exist 2
This condition says that a pathway r is nondecomposable if there is no other pathway for which the reaction set F is a subset of F r . Referring to the definition of genetically independent pathways above it is clear that this definition for non-decomposable pathways and that are very similar-only one deals with genotypes and the other with reaction sets.
In order to illustrate the non-decomposability condition, we show a non-decomposable pathway in Figure 5 and a decomposable pathway in Figure 6 . These pathways were determined from the example metabolic network shown in Figure 1 . We assume that {C2, C5, C8} are internal compounds. The pathway in Figure 5 is nondecomposable since no reaction subset satisfies the stoichiometric constraints [Equations (1) related to internal compounds. The pathway in Figure 6 can be decomposed into two different sub-pathways satisfying the stoichiometric constraints. One of them is precisely the pathway shown in Figure 5 .
Elementary flux modes
Non-decomposable pathways at PSS were termed elementary flux modes (henceforth EFMs) by Schuster and co-workers [26] . The set of EFMs, (e 1 , e 2 , . . ., e q ), is finite and unique for a given metabolic network and a given classification of compounds as internal or external. In order to clarify this concept we computed (using the YANA software package [27] ) the set of EFMs for the example metabolic network in Figure 1 , assuming that {C2, C5, C8} are internal compounds, {C1, C3, C4, C6, C7} are external compounds. Note here that algorithms for computing EFMs effectively deal with reversibility by allowing reversible reactions to take negative values. For this reason it is not necessary to split a reversible reaction into two different reactions, as was done with R6 and R7 in Figure 1 . Subsequently, our input network to YANA included the following reactions: {R1, R2, R3, R4, R5, R6, R8}, with R6 reversible. We obtained the six elementary flux modes (e 1 , e 2 , . . ., e 6 ) shown in Figure 7 . In particular, the fifth elementary flux mode has a negative value for R6, which (for convenience) is depicted here by R7. A SBML file for input to YANA containing the network shown in Figure 1 is available from http://people.brunel.ac. uk/$mastjjb/jeb/network.html As the metabolic network increases in size the number of EFMs explodes in a combinatorial fashion. For example Klamt and Stelling [16] and von Kamp and Schuster [28] 
In the literature the calculation of the set of EFMs has been mostly carried out for the analysis of functional portions of metabolic networks with a limited number of reactions. We briefly summarize below a number of applications of EFMs in different fields, such as metabolic engineering, functional genomics or metabolic diseases. Liao et al. [32] employed EFMs to construct an E. coli strain that efficiently channelled the metabolic flux from carbohydrate to aromatic sugars. Dandekar et al. [33] studied alternative pathways to the classic Glycolysis pathway for different organisms. Förster et al. [34] linked EFMs analysis and metabolomics data in order to assign function to orphan genes in a simplified network of Saccharomyces cerevisiae. Poolman et al. [35] analysed viable pathways in the photosynthate metabolism network of the chloroplast stroma under different conditions. Carlson and Srienc [36] sorted EFMs according to their ATP production for a simplified metabolic network of E. coli. Ç akir et al. [37] evaluated the importance of five deficient enzymes in the central network of human red blood cells.
Special attention has been given in the literature to the methods and algorithms used in Petri Net theory due to its inherent simplicity and ability to model metabolic networks. Petri Nets are bipartite graphs with two types of nodes: places and transitions, which for metabolic networks correspond to compounds and reactions, respectively. The arcs connect places (input compounds) with transitions and transitions with places (output compounds), but there are no arcs between places or between transitions. The stoichiometric coefficients are used as arc weights. A further object, the token, describes the dynamics of a Petri Net. The number of tokens in a place stands for the number of molecules of that compound existing at a given moment. The tokens that exist in the system at a given time describe the state of system, usually called marking. The marking changes when a transition 'fires', according to different firing rules. More as to Petri Nets and their application to metabolic networks can be found in [38] [39] [40] . The analysis of T-invariants in Petri Nets has been of particular interest. A T-invariant is a particular set of transitions such that, after firing, the original marking is restored. T-invariants correspond to pathways at PSS in metabolic networks. Analogously, Petri Net theory contains methods to obtain a subset of T-invariants called minimal T-invariants, which correspond to EFMs in metabolic networks. Colom and Silva [41] presented an algorithm to compute the set of minimal T-invariants. This algorithm has been used to help construct improved algorithms for the computation of EFMs.
Extreme pathways
Schilling et al. [14] proposed a refined view of the set of EFMs named extreme pathways (henceforth EPs). Apart from the PSS and non-decomposability conditions defined above, the set of EPs must satisfy the so-called systemic independence condition, i.e. no EP can be written as a non-trivial nonnegative linear combination of other EPs. So, given a particular set of EFMs, (e 1 , e 2 , . . ., e q ), this set is systemically independent if and only if there does not exist e j & (e 1 , e 2 , . . ., e q ) for which e j ¼ P q i¼1,i6 ¼j i e i where 1 , 2 , . . ., q ! 0 In addition, the set of internal compounds is divided into two subsets: currency compounds and primary compounds. Currency compounds are typical cofactors which are involved in energy and redox levels. Primary compounds are the remaining internal compounds in the metabolic network. Whilst primary compounds must satisfy the PSS condition, currency compounds typically do not. Their paper presented an algorithm to compute the complete set of EPs. The principal differences between EPs and EFMs are:
EPs: satisfy the systemic independence condition; EFMs: do not. EFMs: classify all internal compounds as satisfying PSS; EPs: do not. EPs and EFMs differ as to the metabolic network adopted (e.g. with regard to reversible reactions).
EPs have been classified into three classes: Types I, II and III. Type I EPs are those pathways which produce/consume (in net/aggregate terms) external compounds and currency compounds. Type II EPs, also called futile cycles, only produce/consume (in net/aggregate terms) currency compounds. Type III EPs, sometimes called internal cycles, do not produce/consume (in net/aggregate terms) any external or currency compounds. Classic pathways as found in the literature are generally Types I and II. Type III pathways lack biological interest, as there is not an overall transformation in the pathway.
In order to clarify the classification of EPs, following the example given in Figure 1 , suppose C1 and C7 are external compounds; {C2, C5, C8} are primary compounds; and {C3, C4, C6} are currency compounds. We computed the set of EPs for this particular example using the software package Expa [42] . We obtained seven EPs. Six of these pathways (e 1 , e 2 , . . ., e 6 ) are identical to the six EFMs shown in Figure 7 , the seventh EP e 7 is shown in Figure 8 . Considering Figures 7 and 8 EPs e 1 , e 3 , e 4 , e 5 and e 6 are Type I EPs, as primary and currency compounds are produced and consumed. EP e 2 illustrates a Type II EP in which only currency compounds {C6} are produced. Finally, EP e 7 shows a Type III EP, as no primary or currency compounds are produced or consumed.
Note here that EP e 7 appears due to the fact that the EP approach splits reversible reactions into two reactions, as we did with R6 and R7 in the example metabolic network in Figure 1 . In contrast, the EFM approach allows ticks/flux to be negative in reversible reactions. This is the reason as to why EP e 7 does not appear in the set of EFMs.
Aside from EP e 7 , the set of EFMs and EPs turn out to be the same for our particular small example. Thus, in this example, the systemic independence condition has no effect. One additional point to note here is that, for the sake of simplicity, we have neglected the network configuration to compute the set of EPs, whose main difference is the addition of exchange fluxes. More as to EFMs and EPs can be found in [43, 44] .
As for EFMs, computing the set of EPs suffers a combinatorial explosion when applied to larger networks. For example Yeung et al. [45] estimate that there are 3 Â 10 18 EPs in a 904 reaction metabolic network for E. coli. For work attempting to limit the effect of this explosion see [12, 46] . Whilst EFMs analysis has been applied for different biotechnological or biomedical issues, EPs analysis has usually been focused on elucidating different properties of metabolic networks. Papin et al. [47] calculated the participation of each reaction in the set of EPs so as to find essential reactions in the metabolic network for the production of individual amino acids in Haemophilus influenzae and for individual amino acids and protein production in Helicobacter pylori. Price et al. [48] evaluated the redundancy of the metabolic network of H. pylori to meet its biomass objectives under different conditions.
Discussion
Stoichiometric approaches have proposed a novel mathematical definition for metabolic pathways. A metabolic pathway is considered in those approaches as a set of enzyme catalysed biochemical reactions that satisfy the PSS and non-decomposability conditions (where for ease of discussion we neglect consideration of the systemic independence condition in this section).
The most important constraints are those resulting from the PSS condition. However, the criteria to define whether (or not) a compound is internal has not been clearly stated. Indeed, the decision is often modified by authors in the literature depending on the case being studied. It is clear that this decision is of crucial importance due to the fact that the set of EFMs and EPs changes according to the set of internal compounds.
Another issue arising here is that the PSS condition requires internal compounds to be stoichiometrically balanced, i.e. they do not appear as by-products or co-substrates in the pathway. This does not fully fit with what is known with respect to experimentally determined pathways. We examined the PSS condition in 10 experimentally determined pathways taken from EcoCyc [49] . We used the E. coli model presented in [11] so as to define internal/external compounds. Table 1 summarizes the results, showing that only half of the pathways satisfy the PSS condition (having no unbalanced internal compounds). Thus, there will be a high number of pathways which, as they do not satisfy the PSS condition, will never be determined. Indeed, at a more theoretical level, it is not at all clear why individual pathways in which internal compounds appear as by-products/ co-substrates, thus violating the PSS condition, cannot exist.
One point to note though from Table 1 is that, reflecting the PSS condition for the entire organism, many (but not all) of the internal compounds are balanced in individual pathways, namely 87% ( ¼ 100 Â 53/ (53 þ 8) ) of the compounds. It is clear that a significant step towards ensuring that the PSS condition is satisfied for the entire organism (regarded as the entire set of pathways acting together) can be made if individual pathways themselves satisfy the PSS condition with respect to the majority of compounds involved.
Obviously, the removal of the PSS condition might lead to determination of a high number of insignificant metabolic pathways. However, our view is that this condition should (somehow) be relaxed so as to include the whole set of meaningful metabolic pathways whilst preserving the biological logic of pathways. The addition of constraints, regulatory [50] , topological or energetic [51] , might be helpful to avoid meaningless pathways. However it is clear that the algorithms presented to date to compute EFMs and EPs do not show much flexibility in terms of adding new constraints. The algorithm presented by Schilling et al. [14] for example, does not directly remove Type III pathways and posterior analysis is necessary to eliminate them.
With respect to the non-decomposability condition, our judgement is that the idea of pathways satisfying a simplicity or independence condition is a fruitful one for refining the search for meaningful metabolic pathways. However, to the best of our knowledge, no experimental validation has been carried out so as to show independent operation of a non-decomposable set of pathways. A further limitation lies in the fact that the nondecomposability condition is quite sensitive with respect to the PSS condition [30] .
Assuming that the PSS and non-decomposability conditions are appropriate, the main difficulty EFMs and EPs meet is the combinatorial explosion. Even though different attempts have been made to reduce the number of pathways found, the number is still too high for genome-scale networks to carry out a detailed analysis and interpret the pathways obtained, as noted in [52] . This drawback leads us to question the utility of attempting to find the complete set of EFMs or EPs. Certainly, clear validation (in the sense of whether the EFMs and EPs are biologically meaningful) has only been carried out for networks of small size, e.g. [52] . Type III EPs, for example, illustrate the fact that every EP does not necessarily have biological significance. Therefore, a better strategy might be to find a small number (perhaps 5 to 10) of EPs, or EFMs, under a given optimization criteria. We would make two points here:
Moving from enumerating a large number of possibilities, to generating a small number of possibilities using an optimization approach, is precisely what has happened with regard to pathfinding approaches to metabolic pathways (as will become apparent in the discussion as to these approaches given below). With regard to the optimization criteria to be adopted this is an open research question but there are clear parallels in the literature as to what might be valuable:
Maximize (net) ATP production [53] [54] [55] [56] [57] [58] Minimize the number of reactions [55, [59] [60] [61] [62] [63] [64] Maximize growth (biomass), as is commonly done in flux balance analysis [65] [66] [67] Note here that to avoid the combinatorial explosion new algorithms will have to be developed to find (without excessive enumeration) a small number of EPs, or EFMs, under a given optimization criteria. Here there is a parallel with path-finding approaches, since algorithms have been developed there that find optimal paths without explicitly enumerating all possible paths.
In summary, our view is that the mathematical and computational concept of a metabolic pathway as proposed by stoichiometric approaches should be re-examined, with emphasis placed on generating a small number of pathways via an optimization approach.
PATH-FINDING APPROACHES
Path-finding approaches have emerged as an alternative methodology to analyse metabolic pathways in genome-scale metabolic networks, given the shortcomings of stoichiometric approaches when applied to networks of large size. In contrast to stoichiometric approaches, path-finding approaches do not make use of reaction stoichiometry. Instead, they focus on the fact that there is a (directed) path (containing no cycles) from the source compound to the target compound in experimentally determined metabolic pathways. We refer to this directed path as the metabolic path for a particular experimentally determined metabolic pathway. Of course this path may not be unique, in particular when the pathway is branched. Suppose, for illustration, that the subgraph shown in Figure 2A (and reproduced in Figure 9 , subsequently) is the experimentally determined metabolic pathway that converts C1 into C7. Then in this pathway we have the two metabolic paths shown in Figure 9 .
Note, as in Figure 9 , the difference between a (metabolic) pathway and a metabolic path. The pathway defines all the reactions/compounds involved. The metabolic path is a directed path from the source compound to the target compound in the pathway and may (as in both the metabolic paths seen in Figure 9 ) contain only a subset of the reactions/compounds involved in the pathway.
The key assumption behind path-finding approaches is that finding directed paths between the source compound and the target compound in the entire metabolic network will give insight into the reactions/compounds used in the experimentally determined metabolic pathway between the source/target.
In terms of the experimentally determined metabolic pathway we need only focus on the reactions involved in the metabolic path (since for each reaction we know the set of compounds involved). Both of the metabolic paths shown in Figure 9 involve reactions R1, R2 and R3. Since these are the only reactions involved in the metabolic pathway then, for this example, knowledge of either of the metabolic paths shown in Figure 9 would give us complete insight into the underlying experimentally determined metabolic pathway also shown in Figure 9 . Note here that with respect to the stoichiometry of the metabolic pathway shown then, once the set of reactions involved in the metabolic path are known, it is a relatively simple matter (albeit possibly involving some decisions as to which compounds should be balanced with respect to production and consumption) to deduce the stoichiometry of the pathway. With respect to deciding which compounds might be balanced with respect to production and consumption we would note that the intermediate compounds in the metabolic path are themselves often balanced compounds. This can be seen, for example, in Table 1 above where 87% of the internal compounds in 10 example pathways are balanced.
Küffner et al. [68] described the metabolic network as a Petri Net, where there are two types of nodes, places (compounds) and transitions (reactions). The arcs connect places (input compounds) with transitions and transitions with places (output compounds). Paths are formed via a 'firing rule'. The solution approach adopted was a branch and bound algorithm. They found that there were over 500 000 paths from glucose to pyruvate. Their firing rule reduced the total number of paths to $80 000. This was reduced to 170 paths by imposing further restrictions.
The large number of possible paths identified in [68] illustrated that a complete enumeration of paths from the source compound to the target compound made an analysis of all paths infeasible, thus a more sophisticated approach was needed. Accordingly, the focus of path-finding work has moved to defining a suitable distance metric on the directed graph representation of the metabolic network and finding the shortest path from the source node to the target node (i.e. an optimization criteria is applied, of all possible paths to find the shortest). Often approaches in the literature move beyond considering just the shortest path to consider the k-shortest paths (for small values of k). For readers unfamiliar with the concept of k-shortest paths k ¼ 1 corresponds to the shortest path; k ¼ 2 corresponds to the second shortest path; k ¼ 3 to the third shortest path; etc. These k-shortest paths are (in graph-theoretic terms) simple, i.e. no node is revisited in the path. Here we see, early in the pathfinding literature, a move from enumeration of all possibilities to generating a small number of possibilities using an optimization approach. As commented above this is a move that has yet to take place with regard to stoichiometric approaches.
Arita [4] proposed the use of a k-shortest path algorithm to find paths in metabolic networks, where compounds are represented at the atomic level. The approach was applied to a number of example pathways, where 'shortest' was interpreted as minimizing the number of arcs (reactions) involved in the path. McShan et al. [69] considered metabolic pathways in terms of a biochemical statespace: compounds define the states and reactions define the state transitions. The problem of finding metabolic paths is viewed as searching for a path from an initial state to a destination state through a series of transitions. An algorithm to minimize the cost of the transitions was applied, however, no biological validation was carried out to examine the accuracy of the approach.
Dooms et al. [70] proposed the use of constraint programming to find constrained paths in metabolic networks. One limitation is that in their work they need to know some of the reactions participating in the metabolic path that represents the metabolic pathway. In addition, they note that their approach cannot guarantee to find the optimal constrained shortest path. In [71] there are no reaction nodes in the metabolic network, only compound nodes. Edges between any two compounds are assigned according to their structural similarity. A breadth-first search algorithm was applied to compute the k-shortest paths between an initial source compound and a final target compound.
Croes et al. [2, 3] presented a path-finding approach that utilizes connectivity. They define connectivity, for a compound, to be the number of reactions (in the metabolic network) in which the compound participates (either as an input compound or as an output compound). They define connectivity for a reaction node to be one. Node connectivities are the distance metric to be minimized when finding shortest paths. They use a depth-first backtracking (tree search) algorithm to find the k-shortest paths (k ¼ 1, 2, 3, 4, 5) between a source reaction and a target reaction They systematically compare the k-shortest paths that they find with a number of metabolic pathways. A detailed analysis of pathfinding approaches under a similar metric distance to [2, 3] has been carried out in [6] . Evidence presented in these papers indicates that biologically meaningful pathways can be found using k-shortest path approaches.
Although outside the scope of this article, note here that path-finding approaches are broadly used in different biological contexts. In particular, a number of approaches have been proposed to detect biologically meaningful pathways in protein interaction networks [72] [73] [74] [75] . Essentially these approaches carry out a search for shortest paths where the cardinality of the path (the number of nodes it contains) is specified/constrained. Further reading can be found in [76] [77] [78] .
Discussion
We believe path-finding approaches constitute a considerable advance with respect to stoichiometric approaches for several reasons:
The problem of finding k-shortest paths from a source to a target is a well-known problem in graph theory and computationally tractable for genome-scale metabolic networks The problem as to define which compounds are internal and which external, as required for EFMs and EPs, is avoided Computing k-shortest paths according to a suitable distance metric, instead of computing all paths, appears to be a quite logical concept as not necessarily all the computed paths will have biological significance. In addition, analysis of the computed metabolic paths becomes simpler since we usually restrict k to a very small number.
In order to determine biologically meaningful metabolic paths, the key decision is choice of an appropriate distance metric. The distance metric proposed in [2, 3] appears to be the most effective to date presented in the literature.
One major drawback of path-finding approaches, however, is that they are relatively inflexible in terms of adding additional, biologically meaningful, constraints. The biological significance of the paths found is implicitly completely determined by the distance metric adopted. Currently, for example, even deducing stoichiometric information for a metabolic path must be done as a separate stage (e.g. by balancing intermediate compounds in the path), once the path has been computed without using stoichiometric information. Being able to add biologically based constraints, e.g. stoichiometric, regulatory [50] , topological or energetic [51] , as an intrinsic part of the pathfinding process, would significantly refine the search for biologically meaningful metabolic paths; provided this can be done without excessively complicating the algorithmic/computational expense of finding k-shortest paths.
CONCLUSIONS
In this article stoichiometric and path-finding approaches to metabolic pathways have been considered. Despite the fact that stoichiometric approaches have a theoretical basis, elementary flux modes and extreme pathways encounter severe difficulties when applied to genome-scale networks from both the computational and analytic point of view. With regard to approaches of this kind our judgement is that the key research challenge is to move from enumeration of all possibilities to generating a small number of possibilities using an optimization approach, and we suggested a number of possible optimization criteria based on parallels in the literature.
In contrast to stoichiometric approaches, pathfinding approaches do enable analysis of genomescale metabolic networks to be performed. With regard to approaches of this kind we believe that the key research challenges are choice of an appropriate distance metric and addition of biologically based constraints.
We would emphasize here that pathways produced by any mathematical/computational approach need clear validation against experimentally determined metabolic pathways from the biochemical literature.
Being better able to model mathematically metabolic pathways will help in the metabolic engineering of organisms to create (currently) unknown, novel, pathways useful for biotechnological or biomedical purposes.
